AU2020325517B2 - Alcohol derivatives as KV7 potassium channel openers - Google Patents

Alcohol derivatives as KV7 potassium channel openers

Info

Publication number
AU2020325517B2
AU2020325517B2 AU2020325517A AU2020325517A AU2020325517B2 AU 2020325517 B2 AU2020325517 B2 AU 2020325517B2 AU 2020325517 A AU2020325517 A AU 2020325517A AU 2020325517 A AU2020325517 A AU 2020325517A AU 2020325517 B2 AU2020325517 B2 AU 2020325517B2
Authority
AU
Australia
Prior art keywords
difluoromethoxy
phenyl
ethyl
trifluoromethoxy
hydroxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2020325517A
Other languages
English (en)
Other versions
AU2020325517A1 (en
Inventor
Shu Hui Chen
Debasis DAS
Jian Hong
Krestian Larsen
Mario Rottländer
Anette Graven Sams
Xiaofang Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
H Lundbeck AS
Original Assignee
H Lundbeck AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by H Lundbeck AS filed Critical H Lundbeck AS
Publication of AU2020325517A1 publication Critical patent/AU2020325517A1/en
Application granted granted Critical
Publication of AU2020325517B2 publication Critical patent/AU2020325517B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/26—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being saturated and containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/42—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
    • C07C255/44—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms at least one of the singly-bound nitrogen atoms being acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Epidemiology (AREA)
  • Psychology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU2020325517A 2019-08-02 2020-07-30 Alcohol derivatives as KV7 potassium channel openers Active AU2020325517B2 (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
EP19189750.3 2019-08-02
EP19189750 2019-08-02
CN201910734123 2019-08-09
CN201910734123.0 2019-08-09
EP19191887 2019-08-15
EP19191887.9 2019-08-15
PCT/EP2020/071520 WO2021023617A1 (en) 2019-08-02 2020-07-30 Alcohol derivatives as kv7 potassium channel openers

Publications (2)

Publication Number Publication Date
AU2020325517A1 AU2020325517A1 (en) 2022-02-24
AU2020325517B2 true AU2020325517B2 (en) 2025-08-28

Family

ID=71894829

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2020325517A Active AU2020325517B2 (en) 2019-08-02 2020-07-30 Alcohol derivatives as KV7 potassium channel openers

Country Status (26)

Country Link
EP (2) EP4007634B1 (https=)
JP (2) JP7720829B2 (https=)
CN (1) CN114206830B (https=)
AU (1) AU2020325517B2 (https=)
BR (1) BR112021006324A2 (https=)
CA (1) CA3148719A1 (https=)
CL (1) CL2022000221A1 (https=)
CO (1) CO2022000080A2 (https=)
CR (1) CR20220028A (https=)
DO (1) DOP2022000026A (https=)
EC (1) ECSP22008993A (https=)
ES (1) ES2989376T3 (https=)
GE (2) GEAP202415862A (https=)
HR (1) HRP20241444T1 (https=)
HU (1) HUE069310T2 (https=)
IL (1) IL290193B2 (https=)
JO (1) JOP20220017A1 (https=)
MA (1) MA56708B1 (https=)
MX (1) MX2022001063A (https=)
PE (1) PE20220345A1 (https=)
PH (1) PH12022550192A1 (https=)
PL (1) PL4007634T3 (https=)
RS (1) RS66130B1 (https=)
SM (1) SMT202400445T1 (https=)
WO (1) WO2021023617A1 (https=)
ZA (1) ZA202109598B (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS66130B1 (sr) * 2019-08-02 2024-11-29 H Lundbeck As Derivati alkohola kao otvarači kv7 kalijumovih kanala
IL325387A (en) * 2023-06-27 2026-02-01 Saniona As KV7 modulators

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006033844A2 (en) * 2004-09-15 2006-03-30 Bristol-Myers Squibb Company 4-arylspirocycloalkyl-2-aminopyrimidine carboxamide kcnq potassium channel modulators
WO2019161877A1 (en) * 2018-02-20 2019-08-29 H. Lundbeck A/S Alcohol derivatives as kv7 potassium channel openers

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001092526A1 (en) 2000-05-26 2001-12-06 Bristol-Myers Squibb Company Human kcnq5 potassium channel, methods and compositions thereof
WO2001096540A2 (en) 2000-06-11 2001-12-20 Dupont Pharmaceuticals Company Hepatitis c protease exosite for inhibitor design
TWI453013B (zh) 2006-02-07 2014-09-21 Lundbeck & Co As H N-(2,4-二甲基-6-嗎啉-4-基-吡啶-3-基〉3,3-二甲基-丁醯胺之用途以及包含該化合物之醫藥品
WO2007104717A1 (en) * 2006-03-15 2007-09-20 Neurosearch A/S Quinazolinones and their use as potassium channels activators
AR070513A1 (es) 2007-08-01 2010-04-14 Lundbeck & Co As H Uso de abridores de canales de potasio kcnq para reducir los sintomas o tratar desordenes o afecciones en las cuales se encuentra anulado el sis-tema dopaminergico como por ejemplo esquizofrenia y trastorno depresivo mayor
TW201024286A (en) * 2008-11-27 2010-07-01 Neurosearch As Novel compounds
HK1216095A1 (zh) * 2012-12-10 2016-10-14 H. Lundbeck A/S 烟碱乙酰胆碱受体的新的正向别构调节剂
WO2014145852A2 (en) * 2013-03-15 2014-09-18 Knopp Biosciences Llc Imidazo(4,5-b) pyridin-2-yl amides as kv7 channel activators
SMT202300362T1 (it) * 2014-09-12 2023-11-13 Biohaven Therapeutics Ltd Benzoimidazol-1,2-il-ammidi come attivatori di canale kv7
JP2017095366A (ja) 2015-11-18 2017-06-01 持田製薬株式会社 新規ビアリールアミド誘導体
CN105663136A (zh) * 2016-01-15 2016-06-15 河北中医学院 法舒地尔作为制备选择性Kv7离子通道激活剂药物的应用
RS66130B1 (sr) * 2019-08-02 2024-11-29 H Lundbeck As Derivati alkohola kao otvarači kv7 kalijumovih kanala
CN114206328B (zh) * 2019-08-02 2024-09-17 H.隆德贝克有限公司 用于在癫痫或癫痫发作中使用的作为Kv7钾通道开放剂的醇衍生物

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006033844A2 (en) * 2004-09-15 2006-03-30 Bristol-Myers Squibb Company 4-arylspirocycloalkyl-2-aminopyrimidine carboxamide kcnq potassium channel modulators
WO2019161877A1 (en) * 2018-02-20 2019-08-29 H. Lundbeck A/S Alcohol derivatives as kv7 potassium channel openers

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Blom, S. M., et al. "From pan-reactive KV7 channel opener to subtype selective opener/inhibitor by addition of a methyl group." PloS One, 2014, 9(6): e100209. *

Also Published As

Publication number Publication date
CA3148719A1 (en) 2021-02-11
JP7720829B2 (ja) 2025-08-08
JP2025160211A (ja) 2025-10-22
RS66130B1 (sr) 2024-11-29
KR20220041084A (ko) 2022-03-31
JOP20220017A1 (ar) 2023-01-30
GEAP202415862A (en) 2024-01-25
ES2989376T3 (es) 2024-11-26
CO2022000080A2 (es) 2022-01-17
SMT202400445T1 (it) 2024-11-15
HRP20241444T1 (hr) 2024-12-20
CR20220028A (es) 2022-03-02
DOP2022000026A (es) 2022-03-31
CN114206830B (zh) 2024-07-30
PH12022550192A1 (en) 2022-11-21
GEP20247629B (en) 2024-06-10
ECSP22008993A (es) 2022-03-31
MA56708B1 (fr) 2024-12-31
IL290193B1 (en) 2024-08-01
PE20220345A1 (es) 2022-03-14
IL290193A (en) 2022-03-01
IL290193B2 (en) 2024-12-01
ZA202109598B (en) 2024-04-24
WO2021023617A1 (en) 2021-02-11
EP4007634B1 (en) 2024-10-02
MX2022001063A (es) 2022-02-14
EP4461725A3 (en) 2025-01-15
EP4461725A2 (en) 2024-11-13
PL4007634T3 (pl) 2024-11-25
AU2020325517A1 (en) 2022-02-24
HUE069310T2 (hu) 2025-02-28
CN114206830A (zh) 2022-03-18
BR112021006324A2 (pt) 2022-02-15
EP4007634C0 (en) 2024-10-02
JP2022543203A (ja) 2022-10-11
CL2022000221A1 (es) 2022-10-07
EP4007634A1 (en) 2022-06-08

Similar Documents

Publication Publication Date Title
WO2019161877A1 (en) Alcohol derivatives as kv7 potassium channel openers
US20240327336A1 (en) Alcohol derivatives as kv7 potassium channel openers
AU2020325517B2 (en) Alcohol derivatives as KV7 potassium channel openers
US12258305B2 (en) Alcohol derivatives as Kv7 potassium channel openers
US12508239B2 (en) Alcohol derivatives as Kv7 potassium channel openers for use in epilepsy or seizures
KR102957984B1 (ko) Kv7 칼륨 채널 오프너로서의 알코올 유도체
RU2822797C2 (ru) СПИРТОВЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ СОЕДИНЕНИЙ, ИНДУЦИРУЮЩИХ ОТКРЫТИЕ КАЛИЕВЫХ КАНАЛОВ Kv7
HK40111501A (en) Alcohol derivatives as kv7 potassium channel openers
EA048113B1 (ru) СПИРТОВЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ СОЕДИНЕНИЙ, ИНДУЦИРУЮЩИХ ОТКРЫТИЕ КАЛИЕВЫХ КАНАЛОВ Kv7
HK40099015A (en) Alcohol derivatives as kv7 potassium channel openers
HK40093167A (zh) 作为kv7钾通道开放剂的醇衍生物
HK40042795B (en) Alcohol derivatives as kv7 potassium channel openers
HK40042795A (en) Alcohol derivatives as kv7 potassium channel openers

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)